The findings of this study indicate that MGH is associated with a higher incidence of maternal and neonatal
adverse events. The rates of preterm delivery, PIH and primary cesarean delivery were higher in the study
groups than in the control group. The rate of neonatal hypoglycemia was also higher in the study population